Stock Scorer

Medical Properties Trust Inc (MPT)

Medical Properties Trust Inc reported revenue of 252.1M USD for the quarter ending 31 March 2026, up 12.6% from 223.8M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q1 '26 · ending 31 March 2026 252.1M +12.6%
Gross Profit Q1 '26 · ending 31 March 2026 154.7M +8.7%
Operating Income Q4 '17 · ending 31 December 2017 143.1M +96.7%
Net Income Q1 '26 · ending 31 March 2026 32.8M —
Cost of Revenue Q1 '26 · ending 31 March 2026 97.3M +19.6%
Operating Cash Flow Q1 '26 · ending 31 March 2026 -14.3M -3813.3%
Shares Outstanding Q1 '26 · ending 31 March 2026 597.7M -0.4%
EPS Q1 '26 · ending 31 March 2026 -0.21 —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 972M—-277M—
20242024-12-31 995.5M—-2.4B—
20232023-12-31 871.8M—-556.5M—
20222022-12-31 1.5B—902.6M—
20212021-12-31 1.5B—656M—
20202020-12-31 1.2B—431.4M—
20192019-12-31 854.2M—374.7M—
20182018-12-31 784.5M—1B—
20172017-12-31 704.7M485.6M289.8M—
20162016-12-31 541.1M341.6M225M—

Every period

Revenue Quarterly

PeriodEndingRevenue
Q1 '262026-03-31252.1M
Q4 '252025-12-31270.3M
Q3 '252025-09-30237.5M
Q2 '252025-06-30240.4M
Q1 '252025-03-31223.8M
Q4 '242024-12-31231.8M
Q3 '242024-09-30225.8M
Q2 '242024-06-30266.6M
Q1 '242024-03-31271.3M
Q3 '232023-09-30306.6M
Q2 '232023-06-30337.4M
Q1 '232023-03-31350.2M
Q4 '222022-12-31380.5M
Q3 '222022-09-30352.3M
Q2 '222022-06-30400.2M
Q1 '222022-03-31409.8M
Q4 '212021-12-31409.3M
Q3 '212021-09-30390.8M
Q2 '212021-06-30381.8M
Q1 '212021-03-31362.8M

Gross Profit Quarterly

Revenue minus cost of sales. This filer tags no gross profit of its own..

PeriodEndingGross Profit
Q1 '262026-03-31154.7M
Q4 '252025-12-31258.9M
Q3 '252025-09-30215.2M
Q2 '252025-06-30220.6M
Q1 '252025-03-31142.4M
Q4 '242024-12-31210.7M
Q3 '242024-09-30218M
Q2 '242024-06-30262.2M
Q1 '242024-03-31230.4M
Q3 '232023-09-30277.8M
Q2 '232023-06-30308.7M
Q1 '232023-03-31168.2M
Q4 '222022-12-31364.4M
Q3 '222022-09-30350.5M
Q2 '222022-06-30344.7M
Q1 '222022-03-31315.8M
Q4 '212021-12-31372.4M
Q3 '212021-09-30378.8M
Q2 '212021-06-30371.3M
Q1 '212021-03-31320.7M

Operating Income Quarterly

PeriodEndingOperating Income
Q4 '172017-12-31143.1M
Q3 '172017-09-30120.7M
Q2 '172017-06-30110.3M
Q1 '172017-03-31111.5M
Q4 '162016-12-3172.7M
Q3 '162016-09-3087.9M
Q2 '162016-06-3078.5M
Q1 '162016-03-31102.5M
Q4 '152015-12-3194.6M
Q3 '152015-09-3057.1M
Q2 '152015-06-3047.9M
Q1 '152015-03-3163.7M
Q4 '142014-12-3137.3M
Q3 '142014-09-3053.2M
Q2 '142014-06-3023.8M
Q1 '142014-03-3128.7M
Q4 '132013-12-3133.7M
Q3 '132013-09-3040.5M
Q2 '132013-06-3038.6M
Q1 '132013-03-3140.8M

Net Income Quarterly

PeriodEndingNet Income
Q1 '262026-03-3132.8M
Q4 '252025-12-3117.3M
Q3 '252025-09-30-77.7M
Q2 '252025-06-30-98.4M
Q1 '252025-03-31-118.3M
Q4 '242024-12-31-412.8M
Q3 '242024-09-30-801.2M
Q2 '242024-06-30-320.6M
Q1 '242024-03-31-875.6M
Q4 '232023-12-31-663.9M
Q3 '232023-09-30116.7M
Q2 '232023-06-30-42M
Q1 '232023-03-3132.8M
Q3 '222022-09-30221.8M
Q2 '222022-06-30189.6M
Q1 '222022-03-31631.7M
Q4 '212021-12-31206.5M
Q3 '212021-09-30171.1M
Q2 '212021-06-30114.6M
Q1 '212021-03-31163.8M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q1 '262026-03-3197.3M
Q4 '252025-12-3111.4M
Q3 '252025-09-30-22.3M
Q2 '252025-06-3019.8M
Q1 '252025-03-3181.4M
Q4 '242024-12-3121.1M
Q3 '242024-09-307.8M
Q2 '242024-06-304.3M
Q1 '242024-03-3140.9M
Q4 '232023-12-31-72.1M
Q3 '232023-09-3028.8M
Q2 '232023-06-30-28.7M
Q1 '232023-03-31182.1M
Q4 '222022-12-3116.1M
Q3 '222022-09-301.8M
Q2 '222022-06-3055.6M
Q1 '222022-03-3194M
Q4 '212021-12-3136.9M
Q3 '212021-09-3012M
Q2 '212021-06-3010.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q1 '262026-03-31-14.3M
Q4 '252025-12-31160.1M
Q3 '252025-09-3018.6M
Q2 '252025-06-3051.7M
Q1 '252025-03-31384K
Q4 '242024-12-3176.7M
Q3 '242024-09-3059.2M
Q2 '242024-06-3035.3M
Q1 '242024-03-3174.3M
Q4 '232023-12-31135.4M
Q3 '232023-09-30158.2M
Q2 '232023-06-3076.5M
Q1 '232023-03-31135.6M
Q4 '222022-12-31181.1M
Q3 '222022-09-30213.9M
Q2 '222022-06-30164.6M
Q1 '222022-03-31179.4M
Q4 '212021-12-31234.2M
Q3 '212021-09-30212.2M
Q2 '212021-06-30176.5M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q1 '262026-03-31597.7M
Q3 '252025-09-30601.1M
Q2 '252025-06-30600.8M
Q1 '252025-03-31600.6M
Q3 '242024-09-30600.2M
Q2 '242024-06-30600.1M
Q1 '242024-03-31600.3M
Q3 '232023-09-30598.6M
Q2 '232023-06-30598.3M
Q1 '232023-03-31598.3M
Q3 '222022-09-30599.3M
Q2 '222022-06-30599M
Q1 '222022-03-31598.9M
Q3 '212021-09-30597.3M
Q2 '212021-06-30589.1M
Q1 '212021-03-31577.5M
Q3 '202020-09-30532.4M
Q2 '202020-06-30528.9M
Q1 '202020-03-31522.2M
Q4 '192019-12-31494.9M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q1 '262026-03-31-0.21
Q4 '252025-12-31-0.46
Q3 '252025-09-30-1.18
Q2 '252025-06-30-2.39
Q1 '252025-03-31-2.77
Q4 '242024-12-31-4.03
Q3 '242024-09-30-4.45
Q2 '242024-06-30-2.92
Q1 '242024-03-31-2.45
Q4 '232023-12-31-0.94
Q3 '222022-09-302.09
Q2 '222022-06-302.01
Q1 '222022-03-311.88
Q4 '212021-12-311.11
Q3 '212021-09-300.96
Q2 '212021-06-300.92
Q1 '212021-03-310.94
Q4 '202020-12-310.81
Q3 '202020-09-300.87
Q2 '202020-06-300.82